Clinical Features and Risk Factors of Rapidly Progressive Systemic Sclerosis in a Single Center in China: Anti-RNA Polymerase III Antibodies as a Predictor

被引:1
|
作者
Yu, Qiuxia [1 ,2 ]
Zhang, Jin [1 ,2 ]
Fan, Liyi [3 ]
Yu, Tianhang [3 ]
Liu, Bingbing [1 ,2 ]
Ding, Jian [1 ,2 ]
机构
[1] Lihuili Hosp, Ningbo Med Ctr, Dept Rheumatol & Clin Immunol, Ningbo 315040, Zhejiang, Peoples R China
[2] Ningbo Univ, Li Huili Hosp, Dept Rheumatol & Clin Immunol, Ningbo 315040, Zhejiang, Peoples R China
[3] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China
关键词
rapidly progressive systemic sclerosis; clinical characteristics; predictors; anti-RNA polymerase III antibodies; malignancy; AUTOANTIBODIES; INVOLVEMENT;
D O I
10.24976/Discov.Med.202335175.20
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: Systemic sclerosis (SSc) have been classified in two clinical subsets (diffuse and limited) based on the extend of skin thickening. In this study, we classified a novel subset of SSc defined rapidly progressive systemic sclerosis (RPSSc), which based on the rate of skin thickening progression and the progressive of interstitial lung disease (ILD). We aimed to evaluate RPSSc clinical characteristics and predictive factors in a Chinese single center. Method: Overall, 75 patients diagnosed with SSc, classified into RPSSc (n = 14) and non-rapidly progressive SSc (non-RPSSc, n = 61) were retrospectively included in the study. Clinical characteristics, disease severity and autoantibodies were collected. Logistic regression, least absolute shrinkage, and selection operator (LASSO) regression analysis was used to identify RPSSc predictors. Receiver operating characteristic (ROC) analysis and Delong test was conducted to evaluate and compare different indexes.Results: RPSSc rate was 18.7%. ILD (64.3%), cardiac involvement (42.9%) were the most common organ system involvement of RPSSc, while Raynaud's phenomenon incidence significantly decreased. Disease duration (12 vs 72, months), sex (42.9% vs 11.5%, male %), SSc subset (85.7% vs 27.9%, diffuse cutaneous SSc (dsSSc) %), modified Rodnan total skin score (mRSS) (20.5 vs 6), Raynaud's phenomenon (64.3% vs 98.4%), cardiac involvement (42.9% vs 18%), higher incidence with malignancy (28.6% vs 1.6%) and positive anti-RNA polymerase III antibodies (ARA) (64.3% vs 1.6%) were statistically significant differences among the RPSSc groups and non-RPSSc groups (p < 0.05). Univariate analysis showed that positive ARA, male, dsSSc and malignancy were RPSSc risk factors, while long-disease duration, Raynaud's phenomenon was RPSSc protective factors. ARA was the strongest factor associated to RPSSc (OR 108, 95% CI 11.287-1033.327, p < 0.001). LASSO logistic regression model identified six factors: Disease duration, dsSSc, malignancy, cardiac involvement, positivity of ARA were RPSSc risk factors, Raynaud's phenomenon was RPSSc protective factors.Conclusions: RPSSc is an SSc clinical category which should be accounted for early detection of organ involvement and close follow-up of malignancy. ARA might be used as a predictor for RPSSc and organ involvement.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 50 条
  • [31] Diversity and Epitope Spreading of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis: A Potential Biomarker for Skin and Lung Involvement
    Kotani, Hirohito
    Matsuda, Kazuki M.
    Yamaguchi, Kei
    Ono, Chihiro
    Kogo, Emi
    Ogawa, Koji
    Kobayashi, Yuki
    Hisamoto, Teruyoshi
    Kawanabe, Ruriko
    Kuzumi, Ai
    Fukasawa, Takemichi
    Yoshizaki-Ogawa, Asako
    Goshima, Naoki
    Sato, Shinichi
    Yoshizaki, Ayumi
    ARTHRITIS & RHEUMATOLOGY, 2025, 77 (01) : 67 - 79
  • [32] Immunogenetics and clinical features in scleroderma patients with either anti-topoisomerase-I or anti-RNA polymerase III antibodies
    Rands, A. L.
    Harvey, G. R.
    Susol, E.
    Herrick, A.
    McHugh, N. J.
    RHEUMATOLOGY, 2001, 40 : 118 - 118
  • [33] Clinical Phenotype of Systemic Sclerosis Patients with Anti-RNA Polymerase III Antibodies: A New French Cohort, Systematic Review and Meta-Analysis
    Sobanski, Vincent
    Dauchet, Luc
    Lefevre, Guillaume
    Lambert, Marc
    Morell-Dubois, Sandrine
    Sy, Thierno
    Hachulla, Eric
    Hatron, Pierre-Yves
    Dubucquoi, Sylvain
    Launay, David
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1181 - S1182
  • [34] Anti-RNA polymerase antibodies in systemic sclerosis (SSc): Association with anti-topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II
    Harvey, GR
    Rands, AL
    McHugh, NJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (03): : 468 - 474
  • [35] Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis
    Saigusa, Ryosuke
    Asano, Yoshihide
    Nakamura, Kouki
    Yamashita, Takashi
    Ichimura, Yohei
    Takahashi, Takehiro
    Toyama, Tetsuo
    Taniguchi, Takashi
    Yoshizaki, Ayumi
    Miyazaki, Miki
    Tamaki, Zenshiro
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2016, 43 (07): : 808 - 810
  • [36] Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis
    Campochiaro, Corrado
    Lytton, Simon
    Nihtyanova, Svetlana
    Fuchs, Dietmar
    Ong, Voon H.
    Denton, Christopher P.
    CLINICAL IMMUNOLOGY, 2019, 199 : 18 - 24
  • [37] Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti-RNA Polymerase III Autoantibodies
    Hamaguchi, Yasuhito
    Kodera, Masanari
    Matsushita, Takashi
    Hasegawa, Minoru
    Inaba, Yuki
    Usuda, Toshikazu
    Kuwana, Masataka
    Takehara, Kazuhiko
    Fujimoto, Manabu
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (04) : 1045 - 1052
  • [38] SCREENING FOR MALIGNANCIES IN SYSTEMIC SCLEROSIS PATIENTS POSITIVE FOR ANTI-RNA POLYMERASE III ANTIBODIES: A DELPHI EXERCISE AMONG EUSTAR EXPERTS
    Lazzaroni, M. G.
    Cavazzana, I.
    Airo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 541 - 541
  • [39] ANTI-RNA POLYMERASE III ANTIBODIES ARE ASSOCIATED WITH PROXIMAL SKIN INVOLVEMENT, INCREASED RISK OF RENAL CRISIS AND ANEMIA IN A FRENCH COHORT OF SYSTEMIC SCLEROSIS PATIENTS
    Emilie, S.
    Goulvestre, C.
    Berezne, A.
    Pagnoux, C.
    Guillevin, L.
    Mouthon, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S137 - S137
  • [40] Increased apoptosis in circulating lymphocyte cultures of anti-RNA polymerase III positive patients with systemic sclerosis
    Franca Majone
    Silvia Olivieri
    Franco Cozzi
    Anna Montaldi
    Marta Tonello
    Maria Serena Visentin
    Luca Ciprian
    Amelia Ruffatti
    Rheumatology International, 2009, 29 : 891 - 895